Invesco Pharmaceuticals ETF
PJP
93 hedge funds and large institutions have $101M invested in Invesco Pharmaceuticals ETF in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 11 closing their positions.
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
12% more funds holding
Funds holding: 83 → 93 (+10)
5.94% less ownership
Funds ownership: 32.3% → 26.36% (-5.9%)
13% less capital invested
Capital invested by funds: $116M → $101M (-$15.6M)
43% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$3.06M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.86M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.61M |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$974K |
| 5 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
+$659K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$32.2M |
| 2 |
IMC Chicago
Chicago,
Illinois
|
-$3.07M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$859K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$772K |
| 5 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$701K |
PJP Hedge Fund Activity: Q4 2019 in Review
93 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2019, worth a combined $101M — down 13% from $116M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new PJP positions and 11 closed out — a net gain of 11 holders — while 17 added to existing stakes and 30 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $3.06M. The largest seller was Bank of America, cutting an estimated $32.2M.
- 93 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2019, up from 83 in Q3 2019.
- Funds reported $101M of Invesco Pharmaceuticals ETF stock for Q4 2019, down 13% quarter-over-quarter.
- 22 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2019 and 11 closed out, a net change of +11 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2019 was Goldman Sachs, an estimated $3.06M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2019 was Bank of America, an estimated $32.2M sold.
Based on aggregated 13F filings for Q4 2019.